Pharmanex Pursues Balanced Portfolio of Scientific Research

Q&A with Carsten Smidt, VP of Global R&D for Pharmanex

NBJ: How do you decide which scientific studies Pharmanex should pursue and at what level?

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.